Irina Vladimirovna Osipova

Irina Vladimirovna Osipova

Auto-generated profile, based on publicly available information

Irina Vladimirovna Osipova

Altay State Medical University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
NPN. V. Pogosova
N. V. Pogosova
ROR. G. Oganov
R. G. Oganov
SBSergey Boytsov
Sergey Boytsov
AAA. K. Ausheva
A. K. Ausheva
OSO. Yu. Sokolova
O. Yu. Sokolova
ЮПЮ. М. Поздняков
Ю. М. Поздняков
Анализ ключевых показателей вторичной профилактики у пациентов с ишемической болезнью сердца в России и Европе по результатам российской части международного многоцентрового исследования EUROASPIRE V

18 August 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
OAO. N. Antropova
O. N. Antropova
NPN. V. Pyrikova
N. V. Pyrikova
IOI. V. Osipova
I. V. Osipova

31 August 2021 in Kardiologiia
Verified
Journal Article
Open access
PDF file
NPN. V. Pogosova
N. V. Pogosova
SBSergey Boytsov
Sergey Boytsov
AAA. K. Ausheva
A. K. Ausheva
OSO. Y. Sokolova
O. Y. Sokolova
AAA. A. Arutyunov
A. A. Arutyunov
YPYu. M. Pozdnyakov
Yu. M. Pozdnyakov
Aim To study the practice of drug treatment of ischemic heart disease (IHD) and the consistency of this practice with the established guidelines. Material and methods Results of the Russian part of the EUROASPIRE V study were compared with the general European population of the study. At ≥6 mos. and <2 years after the discharge from the hospital, patients were invited to visit the site for an interview. The drug therapy recommended upon discharge and taken by patients in the long-term as well as the patients’ compliance with the treatment were analyzed. In Russian centers, 699 patients were registered, and 399 of them visited the centers for the interview. Results Upon discharge from the hospital, patients of the Russian cohort and of the entire study population were prescribed acetylsalicylic acid or other antiplatelet drugs (99.2% and 94.1%, respectively); beta-blockers (87.2 and 81.6%, respectively); angiotensin-converting enzyme (ACE) inhibitors (69.9% and 61.1%, respectively); sartans (16.5% and 14.2 %, respectively); calcium channel blockers (19.3 and 19.4 %, respectively); nitrates (8.0% and 22.5 %, respectively); diuretics (31.1 and 32.5 %, respectively); statins (98.0% and 85.0 %, respectively); and anticoagulants (6.6 and 8.3 %, respectively). For the long-term treatment, patients of the Russian cohort and of the entire study population took antiplatelets (94.7 % and 92.5 %, respectively); beta-blockers (83.2% and 81.0 %, respectively); ACE inhibitors (60.2% and 57.3 %, respectively); sartans (19.3% and 18.4 %, respectively); calcium antagonists (21.1% and 23.0 %, respectively); nitrates (9.0% and 18.2 %, respectively); diuretics (31.8% and 33.3 %, respectively); statins (88.2% and 80.8 %, respectively); and anticoagulants (8.8% and 8.2 %, respectively). High intensity hypolipidemic therapy was prescribed to 54.0 % of patients in Russian centers and 60.3 % of patients in the entire study. Both Russian and international patients evaluated their compliance with the prescribed medication as high. Conclusion According to results of the EUROASPIRE V study as compared to earlier studies, the practice of drug therapy in Russian patients with IHD has significantly approached European indexes. Further optimization is possible by a more extensive use of high intense hypolipidemic treatment and antidiabetic drugs with a documented positive effect on prognosis of cardiovascular diseases.

7 July 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
NPN. V. Pyrikova
N. V. Pyrikova
NMN. A. Mozgunov
N. A. Mozgunov
IOI. V. Osipova
I. V. Osipova
Aim. To analyze the results of remote monitoring of patients with decompensated heart failure (HF) based on the assessment of quality of life (QOL), self-care ability and adherence to treatment 3 and 6 months after discharge from the hospital.Material and methods. The first group (experimental) consisted of 70 patients who, along with the approved healthcare standard, underwent measures according to the developed model for managing HF patients, including remote monitoring. The second group (control) included 65 patients who received care according to generally accepted algorithms for managing HF patients. In the study group, there were 46% men (69,6±9,4 years) and 54% women (71,7±9,9 years). The control group also included 46% men (70,6±9,1 years) and 54% women (73,0±10,3 years). Class I HF in the first group had 4%, while in the second — 3%; class II HF in both groups occurred in 11%; class III in the first group — 43%, in the second group — 54%, class IV HF in the first group — 41%, in the second group — 32% of patients. We conducted a standard clinical examination, assessed QOL, self-care ability, and adherence to treatment.Results. In the first group, after 3 months, compared with the baseline, the average Minnesota Satisfaction Questionnaire (MSQ) score was lower by 37 (p=0,037), while after 6 months — by 33,6 (p=0,026). After 3 months according to the MSQ, the QOL in the second group was higher by 7,9 points (p=0,0001); according to the Morisky-Green test — lower by 1,2 points (p=0,0003); according to the self-care questionnaire — higher by 4,7 points (p=0,0001) than in the first group. After 6 months, MSQ score in the second group was higher by 10,4 points (p=0,0001), according to the Morisky-Green test — lower by 1,8 points (p=0,0003); according to the self-care questionnaire — higher by 5,6 points (p=0,0001) than in the study group.Conclusion. The developed model for managing HF patients using remote monitoring, in comparison with the generally accepted standards, has led to an increase in QOL, adherence to treatment and self-care ability of patients.

11 June 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AAA. V. Aleksentseva
A. V. Aleksentseva
IOI. V. Osipova
I. V. Osipova
TRT. V. Repkina
T. V. Repkina
Aim. To study the prevalence of behavioral and biological risk factors for noncommunicable diseases among rural residents of the Altai Krai.Material and methods. The object is a sample of male and female population obtained during the ESSE-RF study. The survey was conducted using a standard questionnaire. We assessed the level of blood pressure (BP), total cholesterol, height, weight of the respondents. The study involved 765 people living in rural areas aged 25-64 years, 35,4% of whom were men (n=271) and 64,6% — women (n=494). The mean age was 44,8±11,6 and 45,6±11,8, respectively.Results. The prevalence of hypertension was 40,3% (men, 42,1%; women, 39,4%). In addition, 77,6% of the respondents were informed about their blood pressure. With age, the incidence of elevated blood pressure increases, from 13,8% at 25-34 years to 64% in the 55-64 age group. Obesity was revealed in 34,2% of the population (men, 22,4%; women, 44,9%). Hypercholesterolemia occurs in 56,2% (men, 45,9%; women, 62,4%). The prevalence of diabetes was 4,3% (men, 2,2%; women, 5,7%). The prevalence of smoking in the sample was 24,1% (men, 50,9%; women, 9,6%). Excessive salt intake was found in 60,4%, insufficient consumption of vegetables and fruits — in 62,1% of respondents.Conclusion. The study made it possible to assess the prevalence of risk factors for chronic noncommunicable diseases in rural residents of the Altai Krai. Analysis shows that smoking dominates in men, while obesity and hypercholesterolemia — in women. Among the representatives of both sexes, a high rate of low physical activity and poor nutrition was noted. The data obtained determines the need and priorities for preventive measures to increase the motivation of residents to follow a healthy lifestyle.

25 January 2020 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
OAO. N. Antropova
O. N. Antropova
SSS. B. Silkina
S. B. Silkina
IOI. V. Osipova
I. V. Osipova
TST. L. Smyshlyaeva
T. L. Smyshlyaeva
IBI. V. Batanina
I. V. Batanina
Кардиоваскулярные факторы риска у лиц молодого возраста с высоким нормальным артериальным давлением и эссенциальной артериальной гипертензией